Aliyu Gambo, El-Kamary Samer S, Abimiku Alash'le, Ezati Nicholas, Mosunmola Iwakun, Hungerford Laura, Brown Clayton, Tracy Kathleen J, Obasanya Joshua, Blattner William
Institute of Human Virology, University of Maryland School of Medicine, 725 West Lombard Street S424, Baltimore, MD 21201, USA.
Tuberc Res Treat. 2013;2013:650561. doi: 10.1155/2013/650561. Epub 2013 Jul 16.
Objective. Data on pulmonary tuberculosis (TB) caused by Mycobacterium tuberculosis (MTB) complex in Nigeria are limited. We investigated species of MTB complex in TB cases from northern Nigeria. Methods. New TB suspects were enrolled, screened for HIV and their sputum samples were cultured after routine microscopy. Genotypes MTBC and MTBDRplus were used to characterize the MTB complex species and their resistance to isoniazid and rifampicin. Results. Of the 1,603 patients enrolled, 375 (23%) had MTB complex infection: 354 (94.4%) had Mycobacterium tuberculosis; 20 (5.3%) had Mycobacterium africanum; and one had Mycobacterium bovis (0.3%). Cases were more likely to be male (AOR = 1.87, 95% CI : 1.42-2.46; P ≤ 0.001), young (AOR = 2.03, 95% CI : 1.56-2.65; P ≤ 0.001) and have HIV (AOR = 1.43, 95% CI : 1.06-1.92; P = 0.032). In 23 patients (6.1%), the mycobacterium was resistant to at least one drug, and these cases were more likely to have HIV and prior TB treatment (AOR = 3.62, 95% CI : 1.51-8.84; P = 0.004; AOR : 4.43; 95% CI : 1.71-11.45 P = 0.002 resp.), compared to cases without any resistance. Conclusion. Mycobacterium tuberculosis remained the predominant specie in TB in this setting followed by Mycobacterium africanum while Mycobacterium bovis was rare. The association of TB drug resistance with HIV has implications for TB treatment.
目的。关于尼日利亚结核分枝杆菌(MTB)复合群引起的肺结核(TB)的数据有限。我们调查了尼日利亚北部结核病病例中MTB复合群的种类。方法。纳入新的结核病疑似患者,进行HIV筛查,并在常规显微镜检查后对其痰液样本进行培养。使用MTBC和MTBDRplus基因型来鉴定MTB复合群的种类及其对异烟肼和利福平的耐药性。结果。在纳入的1603名患者中,375例(23%)患有MTB复合群感染:354例(94.4%)为结核分枝杆菌;20例(5.3%)为非洲分枝杆菌;1例为牛分枝杆菌(0.3%)。病例更可能为男性(比值比[AOR]=1.87,95%置信区间[CI]:1.42 - 2.46;P≤0.001)、年轻人(AOR = 2.03,95% CI:1.56 - 2.65;P≤0.001)且感染HIV(AOR = 1.43,95% CI:1.06 - 1.92;P = 0.032)。23例患者(6.1%)的分枝杆菌对至少一种药物耐药,与无任何耐药的病例相比,这些病例更可能感染HIV且曾接受过结核病治疗(分别为AOR = 3.62,95% CI:1.51 - 8.84;P = 0.004;AOR:4.43;95% CI:1.71 - 11.45;P = 0.002)。结论。在该地区,结核分枝杆菌仍然是结核病中的主要菌种,其次是非洲分枝杆菌,而牛分枝杆菌较为罕见。结核病耐药性与HIV的关联对结核病治疗具有重要意义。